Interleukin 6 Signaling Blockade Exacerbates Acute and Late Injury From Focal Intestinal Irradiation.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 20 07 2018
revised: 26 09 2018
accepted: 08 10 2018
pubmed: 20 10 2018
medline: 4 9 2019
entrez: 19 10 2018
Statut: ppublish

Résumé

To evaluate the acute changes in leukocyte populations after focal irradiation and to assess the role of interleukin 6 (IL-6) in acute and late radiation injury. Mice were surgically implanted with a radiopaque marker on the surface of the small intestine. Mice were then imaged with cone beam computed tomography to locate the marker and irradiated with 18 Gy of 5 × 5 mm collimated x-rays onto the marked intestine using the Small Animal Radiation Research Platform. Intestinal sections and blood were harvested 1, 3.5, 7, and 14 days and 2 months postirradiation (post-IR) for histology and complete blood count, respectively. Immune cell populations were assessed by immunofluorescence in the acute phase. Collagen deposition was assessed 2 months post-IR. IL-6 Intestinal radiation damage peaked 14 days post-IR, and fibrosis had developed by 60 days post-IR. There was a marked infiltration of immune cells into the irradiated intestine, with increased neutrophils, macrophages, B-cells, and CD4 Focal irradiation of the intestine produced a significant increase in immune cells in the irradiated area and systemic inflammation and anemia. Blockade of IL-6 signaling was found to exacerbate acute intestinal injury and late intestinal injury after focal irradiation.

Identifiants

pubmed: 30336264
pii: S0360-3016(18)33858-6
doi: 10.1016/j.ijrobp.2018.10.007
pmc: PMC7699458
mid: NIHMS1637444
pii:
doi:

Substances chimiques

Cytokines 0
Interleukin-6 0
Radiation-Protective Agents 0
interleukin-6, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-727

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK019525
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA140116
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Nature. 2016 Jan 21;529(7586):307-15
pubmed: 26791721
Clin Oncol (R Coll Radiol). 2007 Dec;19(10):790-9
pubmed: 17904338
PLoS One. 2016 Dec 9;11(12):e0167195
pubmed: 27936014
Sci Transl Med. 2018 Feb 21;10(429):
pubmed: 29467297
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):187-95
pubmed: 9300754
BMC Surg. 2004 Sep 13;4:10
pubmed: 15363103
Cancer Cell. 2009 Feb 3;15(2):103-13
pubmed: 19185845
J Immunol. 2014 Oct 1;193(7):3755-68
pubmed: 25172494
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):470-9
pubmed: 24686268
Nat Rev Immunol. 2014 Oct;14(10):667-85
pubmed: 25234148
Cancer Res. 2017 Feb 15;77(4):908-917
pubmed: 28011621
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1528-36
pubmed: 16580503
Gastroenterol Res Pract. 2011;2011:917941
pubmed: 22144997
Semin Oncol. 2001 Apr;28(2 Suppl 8):54-9
pubmed: 11395854
Immunity. 2014 Jan 16;40(1):40-50
pubmed: 24412616
Radiat Res. 2017 May;187(5):549-561
pubmed: 28319461
Acta Oncol. 1996;35(1):81-7
pubmed: 8619945
J Pharmacol Exp Ther. 2001 Apr;297(1):35-42
pubmed: 11259525
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
Radiother Oncol. 2014 Jul;112(1):140-4
pubmed: 24833561
J Pathol. 2004 Feb;202(2):145-56
pubmed: 14743496
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):427-34
pubmed: 14751512
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
J Histochem Cytochem. 2014 Oct;62(10):751-8
pubmed: 25023614
World J Gastroenterol. 2008 Dec 14;14(46):7075-85
pubmed: 19084914
Gut. 2010 Feb;59(2):186-96
pubmed: 19074180
Radiat Res. 2000 May;153(5 Pt 1):533-9
pubmed: 10790274
World J Gastroenterol. 2006 Aug 21;12(31):4996-5004
pubmed: 16937495

Auteurs

Brett I Bell (BI)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania.

Sravya Koduri (S)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Carlo Salas Salinas (C)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

James Monslow (J)

Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ellen Puré (E)

Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Edgar Ben-Josef (E)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Constantinos Koumenis (C)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ioannis I Verginadis (II)

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: vioannis@pennmedicine.upenn.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH